146 related articles for article (PubMed ID: 7795422)
1. Thalassemia major 1995: older patients, new therapies.
Rund D; Rachmilewitz E
Blood Rev; 1995 Mar; 9(1):25-32. PubMed ID: 7795422
[TBL] [Abstract][Full Text] [Related]
2. New trends in the treatment of beta-thalassemia.
Rund D; Rachmilewitz E
Crit Rev Oncol Hematol; 2000 Feb; 33(2):105-18. PubMed ID: 10737372
[TBL] [Abstract][Full Text] [Related]
3. Morbidities and mortality in transfusion-dependent Beta-thalassemia patients (single-center experience).
Mokhtar GM; Gadallah M; El Sherif NH; Ali HT
Pediatr Hematol Oncol; 2013 Mar; 30(2):93-103. PubMed ID: 23301991
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the patients with thalassemia major for long-term endocrinological complications after bone marrow transplantation.
Aldemir-Kocabaş B; Tezcan-Karasu G; Bircan I; Bircan O; Aktaş-Samur A; Yeşilipek MA
Pediatr Hematol Oncol; 2014 Oct; 31(7):616-23. PubMed ID: 24852067
[TBL] [Abstract][Full Text] [Related]
5. New approaches to the management of hepatitis and endocrine disorders in Cooley's anemia.
Wonke B; Hoffbrand AV; Bouloux P; Jensen C; Telfer P
Ann N Y Acad Sci; 1998 Jun; 850():232-41. PubMed ID: 9668545
[TBL] [Abstract][Full Text] [Related]
6. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
[TBL] [Abstract][Full Text] [Related]
7. Update on thalassemia: clinical care and complications.
Cunningham MJ
Hematol Oncol Clin North Am; 2010 Feb; 24(1):215-27. PubMed ID: 20113904
[TBL] [Abstract][Full Text] [Related]
8. [Clinical management of beta-thalassaemia].
Thuret I
Rev Prat; 2014 Oct; 64(8):1132-7. PubMed ID: 25510144
[TBL] [Abstract][Full Text] [Related]
9. Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major.
Prati D
Vox Sang; 2000; 79(3):129-37. PubMed ID: 11111230
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of thalassemia major with unrelated donor bone marrow transplantation].
Zhu WG; Feng ZC; Lan HK; Zhang CC; Li QP; Li ZD
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):599-602. PubMed ID: 16191272
[TBL] [Abstract][Full Text] [Related]
11. Update on thalassemia: clinical care and complications.
Cunningham MJ
Pediatr Clin North Am; 2008 Apr; 55(2):447-60, ix. PubMed ID: 18381095
[TBL] [Abstract][Full Text] [Related]
12. Thalassemia.
Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
[TBL] [Abstract][Full Text] [Related]
13. Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.
Shenoy S; Thompson AA
Ann N Y Acad Sci; 2016 Mar; 1368(1):122-6. PubMed ID: 26999376
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation for thalassemia major.
Mathews V; Srivastava A; Chandy M
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1187-200. PubMed ID: 25459187
[TBL] [Abstract][Full Text] [Related]
15. Thalassemia Major: Transplantation or Transfusion and Chelation.
Mohamed SY
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):290-298. PubMed ID: 28651066
[TBL] [Abstract][Full Text] [Related]
16. Update on thalassemia treatment in Taiwan, including bone marrow transplantation, chelation therapy, and cardiomyopathy treatment effects.
Peng CT; Chang JS; Wang LY; Chiou SS; Hsiao CC; Wang SC; Hung GY; Wu KH
Hemoglobin; 2009; 33(5):304-11. PubMed ID: 19814676
[TBL] [Abstract][Full Text] [Related]
17. How I treat thalassemia.
Rachmilewitz EA; Giardina PJ
Blood; 2011 Sep; 118(13):3479-88. PubMed ID: 21813448
[TBL] [Abstract][Full Text] [Related]
18. Thalassemia Minor and Major: Current Management.
Choudhry VP
Indian J Pediatr; 2017 Aug; 84(8):607-611. PubMed ID: 28435994
[TBL] [Abstract][Full Text] [Related]
19. New strategies in the treatment of the thalassemias.
Schrier SL; Angelucci E
Annu Rev Med; 2005; 56():157-71. PubMed ID: 15660507
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
Daar S; Pathare AV
Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
